Trial reportDrug design, development and therapy2026
The Effect of Esketamine on Peripheral Vascular Resistance in Elderly Patients During Anesthesia Induction: A Single-Center, Double-Blind, Prospective, Randomized Controlled Study.
Trial report in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the effect of esketamine on peripheral vascular resistance in elderly patients during anesthesia induction. Patients and Methods: Eighty elderly patients undergoing elective surgery were randomly assigned to two groups (n=40 each): the esketamine group (Group A) received esketamine 0.3 mg/kg, while the control group (Group B) received an equal volume of normal saline. Both groups received the same standard anesthesia induction (etomidate, sufentanil, rocuronium). Hemodynamic parameters (SBP, DBP, MAP, HR) and peripheral vascular resistance assessed by the snuffbox radial artery resistance index (SBRI) were recorded at seven time points: before induction (T1), 1 min (T2) and 5 min (T3) after induction, during intubation (T4), and 1 min (T5), 5 min (T6), and 10 min (T7) after intubation. Adverse events during induction and postoperative recovery were also documented. This double-blind study masked drug administration and outcome assessment. Results: No significant baseline differences existed between groups (P>0.05). MAP in Group A was significantly higher than in Group B at T2-T7 (P<0.05). SBRI in Group A was significantly higher than in Group B at T2 and T3 (P<0.05), but not at T4-T7. Group A had lower incidences of hypotension (14.3% vs 56.4%), muscle tremor (8.6% vs 33.3%), and vasoactive drug use (5.7% vs 38.5%) (all P<0.05). No significant differences were observed in other adverse events or postoperative recovery scores. Postoperative VAS pain score was slightly lower in Group A (P<0.05). Conclusion: Esketamine used during anesthesia induction shows promise in mitigating early-phase blood pressure decline, increasing peripheral vascular resistance (T2-T3), maintaining hemodynamic stability, and reducing hypotension, muscle tremor, and vasoactive drug use in elderly patients, without compromising recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.